Mutant IDH1 inhibition induces dsDNA sensing to activate tumor immunity
Meng‐Ju Wu(Broad Institute), Nabeel Bardeesy(Broad Institute), Wilhelm Haas(Harvard University), Adriana E. Tron, Jihye Paik(Meyer (China)), Lei Shi(Broad Institute), Daniel P. Cahill(Harvard University), Omar I. Avila(Broad Institute), James M. Cleary(Brigham and Women's Hospital), Samuel K. McBrayer(The University of Texas Southwestern Medical Center), Milan R. Savani(Children's Medical Center), Russell W. Jenkins(Broad Institute), Diana D. Shi(Harvard University), Hyo Min Cho(Seoul National University), Yosuke Kitagawa(Harvard University), Prabhat Kattel(Broad Institute), Ilaria Gritti(Broad Institute), Ashwin V. Kammula(Broad Institute), Chloe J. Slater(Harvard University), Kathleen B. Yates(Broad Institute), Jason Eccleston(National Institutes of Health), Vindhya Vijay(Broad Institute), Joshua Merritt(Broad Institute), Raúl Mostoslavsky(Broad Institute), Yi Sun(Broad Institute), Kira E. Olander(Broad Institute), Robert T. Manguso(Broad Institute), Takeshi Katsuda(Tokyo University of Foreign Studies), Hiroyuki Kato(Broad Institute), Hatice D. Saatcioglu(Southwestern Medical Center), Yi Xiao(The University of Texas Southwestern Medical Center), Hiroshi Kondo(University of Tsukuba), Qin Xu(Chinese Academy of Sciences), Bailey Smith(Children's Medical Center), Jonathan Sussman(University of Pennsylvania), Sofiene Dhiab(Broad Institute), Anna M. Tassinari, Hiroaki Wakimoto(Harvard University)
Cited by 87
Related Papers
Patterns of somatic mutation in human cancer genomes
|Nature|2007|3.1k
Defining T Cell States Associated with Response to Checkpoint Immunotherapy in Melanoma
|Cell|2018|2k
Dependency of a therapy-resistant state of cancer cells on a lipid peroxidase pathway
|Nature|2017|2k